Université d'Angers, CHU d'Angers, CRCINA, Angers, France.
Département de Neurochirurgie, CHU Angers, Angers, France.
J Neurooncol. 2021 Jan;151(2):113-121. doi: 10.1007/s11060-020-03666-7. Epub 2021 Jan 4.
Neurosurgeons adopt several different surgical approaches to deal with glioblastomas (GB) located in or near eloquent areas. Some attempt maximal safe resection by awake craniotomy (AC), but doubts persist concerning the real benefits of this type of surgery in this situation. We performed a retrospective study to evaluate the extent of resection (EOR), functional and survival outcomes after AC of patients with GB in critical locations.
Forty-six patients with primary GB treated with the Stupp regimen between 2004 and 2019, for whom brain mapping was feasible, were included. We assessed EOR, postoperative language and/or motor deficits three months after AC, progression-free survival (PFS) and overall survival (OS).
Complete resection was achieved in 61% of the 46 GB patients. The median PFS was 6.8 months (CI 6.1; 9.7) and the median OS was 17.6 months (CI 14.8; 34.1). Three months after AC, more than half the patients asymptomatic before surgery remained asymptomatic, and one third of patients with symptoms before surgery experienced improvements in language, but not motor functions. The risk of postoperative deficits was higher in patients with preoperative deficits or incomplete resection. Furthermore, the presence of postoperative deficits was an independent predictive factor for shorter PFS.
AC is an option for the resection of GB in critical locations. The observed survival outcomes are typical for GB patients in the Stupp era. However, the success of AC in terms of the recovery or preservation of language and/or motor functions cannot be guaranteed, given the aggressiveness of the tumor.
神经外科医生采用多种不同的手术方法来处理位于或靠近功能区的胶质母细胞瘤(GB)。一些医生试图通过清醒开颅术(AC)进行最大程度的安全切除,但对于这种情况下这种手术类型的真正益处仍存在疑问。我们进行了一项回顾性研究,以评估关键部位的 GB 患者在接受 AC 后切除范围(EOR)、功能和生存结局。
我们纳入了 46 名在 2004 年至 2019 年期间接受 Stupp 方案治疗、可行脑映射的原发性 GB 患者。我们评估了 EOR、AC 术后 3 个月的语言和/或运动功能障碍、无进展生存期(PFS)和总生存期(OS)。
46 名 GB 患者中,61%实现了完全切除。中位 PFS 为 6.8 个月(95%CI:6.1;9.7),中位 OS 为 17.6 个月(95%CI:14.8;34.1)。AC 术后 3 个月,超过一半的术前无症状患者仍无症状,三分之一的术前有症状患者语言功能得到改善,但运动功能无改善。术前有缺陷或不完全切除的患者术后发生缺陷的风险更高。此外,术后缺陷的存在是 PFS 缩短的独立预测因素。
AC 是处理关键部位 GB 的一种选择。观察到的生存结果是 Stupp 时代 GB 患者的典型结果。然而,鉴于肿瘤的侵袭性,AC 在语言和/或运动功能的恢复或保留方面的成功不能得到保证。